RENE GONZALEZ to Myeloid-Derived Suppressor Cells
This is a "connection" page, showing publications RENE GONZALEZ has written about Myeloid-Derived Suppressor Cells.
Connection Strength
0.344
-
Targeting MDSC Differentiation Using ATRA: A Phase I/II Clinical Trial Combining Pembrolizumab and All-Trans Retinoic Acid for Metastatic Melanoma. Clin Cancer Res. 2023 04 03; 29(7):1209-1219.
Score: 0.199
-
Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab. Int Immunopharmacol. 2018 Oct; 63:282-291.
Score: 0.145